Collagen Peptides for Hair: What Studies Report
Direct answer: the published evidence that oral collagen peptides improve human hair growth is thin. No large randomized trial has tested collagen peptides alone against placebo for hair as its primary endpoint. The human trials that exist used multi-ingredient supplements containing collagen plus amino acids, iron, selenium, vitamins or zinc, which makes the collagen contribution impossible to isolate. A review of oral collagen supplementation described hair claims as the least supported of the skin, nail and hair categories. Most mechanistic hair findings come from cell and mouse models.
Does the Published Evidence Show That Collagen Peptides Help Hair?
The short answer from the literature is that the human evidence is weak and indirect. A review of oral collagen supplementation for skin, nails and hair concluded that the claims surrounding hair were the least supported of the three categories, with most marketing assertions outrunning the published data (PMID 34694676). The randomized human trials that report hair outcomes tested blended supplements in which hydrolyzed collagen sat alongside amino acids, minerals and vitamins, so no trial in this citation set isolated collagen peptides as the only active variable for hair (PMID 37357646, PMID 41346549). The more striking hair growth results come from cultured human dermal papilla cells and mouse models rather than people (PMID 36233206, PMID 37830229).
This page is for educational purposes only and is not medical advice; consult a licensed physician about hair loss, supplements or any health decision. Nothing here describes how to use any product.
Regulatory Status in the United States
In the United States collagen peptides are sold as a dietary supplement or food ingredient. The Food and Drug Administration does not approve dietary supplements for efficacy before they are sold, and marketing claims are not evaluated for proof of benefit in the way drug claims are. A review of collagen-based products in wound, skin and health care described the breadth of the market and the range of regulatory categories collagen materials fall into (PMID 40720447).
Randomized and Controlled Human Trials Reporting Hair Outcomes
Multi-ingredient supplement in androgenetic alopecia and telogen effluvium
A prospective, randomized, three month, controlled, assessor-blinded study tested an oral supplement containing amino acids, iron, selenium and marine hydrolyzed collagen in subjects with hair loss classified as androgenetic alopecia, female-pattern hair loss or telogen effluvium, and researchers reported on efficacy and tolerability over the three month period (PMID 37357646). The key interpretive limit is composition: because iron and selenium were included alongside marine collagen, the study design cannot attribute any change to the collagen fraction (PMID 37357646). Assessor blinding is a methodological strength relative to open-label work, but a three month window is short relative to the full hair cycle (PMID 37357646).
Hydrolyzed collagen with vitamins and zinc in telogen effluvium
A 2025 study in the International Journal of Trichology examined the effect of a nutritional supplement containing hydrolyzed collagen, vitamins and zinc on telogen effluvium (PMID 41346549). Again the intervention was a combination product, and zinc and vitamin status are themselves linked to shedding, so the collagen contribution was not separable in that design (PMID 41346549). Telogen effluvium also frequently resolves on its own once a trigger passes, which makes a concurrent control group essential to interpretation of any improvement reported in this condition (PMID 41346549).
Placebo-controlled trials with keratinised tissue endpoints other than hair
Two randomized placebo-controlled trials in this citation set measured nails rather than hair growth. A double blind, randomized, placebo-controlled trial in an East Asian population investigated collagen peptide supplementation and visible signs of skin and nail health and aging (PMID 39143887). An earlier open-label study of specific bioactive collagen peptides reported improvements in nail growth and a reduction in brittle nail symptoms (PMID 28786550). Nails and hair are both keratinised appendages, but a nail endpoint is not a hair endpoint, and the brittle nail study relied partly on self-reported symptom change rather than purely instrumental measurement (PMID 28786550).
Doing the math on a vial? The PeptideU app does reconstitution, units and dilution for you.
Try it freeEvidence Table
| Study | Population or model | Comparator | Endpoint | What was reported |
|---|---|---|---|---|
| PMID 37357646 | Adults with androgenetic alopecia, female-pattern loss or telogen effluvium | Controlled, assessor-blinded, 3 months | Hair loss efficacy and tolerability | Efficacy and tolerability of a multi-ingredient supplement with marine hydrolyzed collagen, amino acids, iron and selenium were assessed over three months |
| PMID 41346549 | Subjects with telogen effluvium | Study comparator as described by the authors | Telogen effluvium outcomes | Effect of a hydrolyzed collagen, vitamin and zinc supplement on telogen effluvium was examined |
| PMID 39143887 | East Asian adults | Placebo, double blind | Visible signs of skin and nail health and aging | Collagen peptide supplementation was tested against placebo on skin and nail signs, not hair growth |
| PMID 28786550 | Adults with brittle nails | Within-subject, open-label | Nail growth rate, brittle nail symptoms | Improved nail growth and reduced brittle nail symptoms were reported, with symptom data self-reported |
| PMID 36233206 | Human dermal papilla cells and C57BL/6 mice | Untreated or vehicle controls | Hair growth promotion, signalling | Fish collagen peptide promoted hair growth effects while modulating Wnt/beta-catenin and BMP signalling |
| PMID 37830229 | Preclinical hair growth model | Controls | Hair growth, pathway activation | Low molecular weight collagen peptide promoted hair growth via Wnt/GSK-3beta/beta-catenin signalling |
| PMID 37992979 | Androgenetic alopecia model | Controls | Topical delivery outcome | Marine collagen peptide was incorporated into dissolving microneedles as a delivery approach |
Mechanistic and Preclinical Findings
Laboratory work offers the clearest biological rationale, and it is also the least transferable to people. A 2022 study reported that fish collagen peptide produced hair-growth-promoting effects in human dermal papilla cells and in C57BL/6 mice while modulating Wnt/beta-catenin and BMP signalling pathways (PMID 36233206). A separate investigation reported that a low molecular weight collagen peptide promoted hair growth through activation of the Wnt/GSK-3beta/beta-catenin signalling pathway (PMID 37830229). The Wnt/beta-catenin axis is a well studied driver of the transition from telogen into anagen, which is why these pathway findings attract attention (PMID 37830229).
Mouse skin and human scalp differ in hair cycle synchrony and density, and an effect produced by direct exposure of cultured dermal papilla cells does not establish that an orally ingested peptide reaches the follicle intact at a meaningful concentration (PMID 36233206). Researchers in this space have partly responded by testing delivery routes that bypass digestion: a 2024 paper described an androgenetic alopecia approach based on marine collagen peptide incorporated into dissolving microneedles (PMID 37992979). That is a formulation and delivery study, not a demonstration that oral supplements do the same thing (PMID 37992979).
Hair fibre versus hair follicle
A distinction that is often blurred in popular coverage is between growing new hair and treating the hair shaft that already exists. A 2025 study described a composite fish collagen peptide-based biopolymer emulsion developed for keratin structure stabilisation and hair fibre repair (PMID 40219297). That is a cosmetic material science objective applied to the fibre itself, and it says nothing about follicular growth, density or shedding (PMID 40219297).
Tracking research? Log entries with dates, lots and notes: records, never plans.
Get the appHow Strong Is the Evidence Overall?
Several features limit confidence. First, attribution: the human trials with hair endpoints used multi-ingredient formulations (PMID 37357646, PMID 41346549). Second, endpoint quality: parts of the supportive supplement literature rely on self-reported or subjective appearance ratings rather than phototrichogram or biopsy data (PMID 28786550). Third, sample size and duration: the controlled hair study ran for three months, a short window given hair cycle timescales (PMID 37357646).
Industry involvement is a recognised feature of this field. The review of myths and media in oral collagen supplementation specifically examined the gap between promotional messaging and the underlying evidence for skin, nail and hair claims, and noted the role of industry-linked research in shaping that picture (PMID 34694676). Where funding sources are disclosed, they appear in each paper's own funding statement; readers can confirm them on the linked records rather than relying on a summary (PMID 34694676).
Broader overviews place collagen peptides within the nutricosmetics category, where ingestible products are marketed for skin, nail and hair appearance and where the strength of supporting data varies widely by ingredient and endpoint (PMID 31478301). A 2025 review of collagen supplementation and regenerative health described ongoing work on biomarker detection and smart material integration, which reflects that objective measurement of collagen peptide effects in people remains an active methodological problem rather than a settled one (PMID 41459089).
Gaps the Literature Has Not Filled
- No placebo-controlled trial in this citation set tested collagen peptides alone, with hair density or hair count as the primary endpoint, in people with androgenetic alopecia (PMID 34694676).
- Comparisons between collagen peptides and established hair loss treatments were not reported in the trials cited here (PMID 37357646).
- Long-term follow-up beyond a few months was not described in the controlled hair study available here (PMID 37357646).
- Whether orally ingested collagen peptides reach the dermal papilla in amounts matching those used in cell work has not been demonstrated in the preclinical reports (PMID 36233206).
Want the full course? Every compound, evidence-graded and cited, inside PeptideU.
Start learning freeTolerability: What Studies Report
The controlled hair loss study assessed tolerability alongside efficacy over its three month course (PMID 37357646). Reviews of oral collagen supplementation have generally characterised these products as well tolerated in the trials examined, while noting that trial populations were small and follow-up short, which limits what can be said about uncommon events (PMID 34694676). The nutricosmetics overview likewise discussed safety within the broader ingestible cosmetic category rather than presenting long-term safety data specific to hair outcomes (PMID 31478301). Multi-ingredient formulations introduce an additional consideration, since minerals such as iron and selenium carry their own tolerability profiles independent of collagen (PMID 37357646).
Related Reading
References
- Myths and media in oral collagen supplementation for the skin, nails, and hair: A review (Journal of Cosmetic Dermatology, 2022)
- Efficacy and tolerability of an oral supplement containing amino acids, iron, selenium, and marine hydrolyzed collagen in subjects with hair loss. A prospective, randomized, 3-month, controlled, assessor-blinded study (Skin Research and Technology, 2023)
- Effect of a Hydrolyzed Collagen, Vitamin, and Zinc Containing Nutritional Supplement on Telogen Effluvium (International Journal of Trichology, 2025)
- Influence of collagen peptide supplementation on visible signs of skin and nail health and -aging in an East Asian population: A double blind, randomized, placebo-controlled trial (Journal of Cosmetic Dermatology, 2024)
- Oral supplementation with specific bioactive collagen peptides improves nail growth and reduces symptoms of brittle nails (Journal of Cosmetic Dermatology, 2017)
- Hair-Growth-Promoting Effects of the Fish Collagen Peptide in Human Dermal Papilla Cells and C57BL/6 Mice Modulating Wnt/beta-Catenin and BMP Signaling Pathways (International Journal of Molecular Sciences, 2022)
- Low Molecular Weight Collagen Peptide (LMWCP) Promotes Hair Growth by Activating the Wnt/GSK-3beta/beta-Catenin Signaling Pathway (Journal of Microbiology and Biotechnology, 2024)
- An androgenetic alopecia remedy based on marine collagen peptide-incorporated dissolving microneedles (International Journal of Pharmaceutics, 2024)
- Composite Fish Collagen Peptide-Based Biopolymer Emulsion for Keratin Structure Stabilization and Hair Fiber Repair (Polymers, 2025)
- Collagen-Based Products in Wound, Skin, and Health Care (Advances in Wound Care, 2025)
- Nutricosmetics: A brief overview (Phytotherapy Research, 2019)
- Collagen supplementation and regenerative health: advances in biomarker detection and smart material integration (Frontiers in Nutrition, 2025)
Frequently asked questions
Do collagen peptides help hair growth according to published studies?▾
The human evidence is weak. A review of oral collagen supplementation described hair claims as the least supported of the skin, nail and hair categories (PMID 34694676). Controlled human studies reporting hair outcomes used multi-ingredient supplements containing collagen plus minerals or vitamins, so the collagen contribution could not be isolated (PMID 37357646, PMID 41346549).
Has any trial tested collagen peptides alone for hair?▾
Not within this citation set. The assessor-blinded, randomized three month study combined marine hydrolyzed collagen with amino acids, iron and selenium (PMID 37357646), and the telogen effluvium study combined hydrolyzed collagen with vitamins and zinc (PMID 41346549). A placebo-controlled collagen peptide trial measured skin and nail signs rather than hair growth (PMID 39143887).
What do laboratory studies report about collagen peptides and hair follicles?▾
A 2022 study reported hair-growth-promoting effects of fish collagen peptide in human dermal papilla cells and C57BL/6 mice while modulating Wnt/beta-catenin and BMP signalling (PMID 36233206). Another report described a low molecular weight collagen peptide promoting hair growth through the Wnt/GSK-3beta/beta-catenin pathway (PMID 37830229). These are cell and animal findings, not human outcomes.
Are nail study results relevant to hair?▾
Only indirectly. An open-label study reported improved nail growth and reduced brittle nail symptoms with specific bioactive collagen peptides, with symptom data partly self-reported (PMID 28786550), and a placebo-controlled trial assessed visible skin and nail signs (PMID 39143887). Nails and hair are both keratinised, but a nail endpoint does not establish a hair endpoint.
How are collagen peptides regulated in the United States?▾
They are sold as a dietary supplement or food ingredient. The Food and Drug Administration does not approve dietary supplements for efficacy before sale. A 2025 review outlined the breadth of collagen-based products across wound, skin and health care applications and the varied categories they occupy (PMID 40720447).
Does industry funding affect the collagen and hair literature?▾
A review examining myths and media in oral collagen supplementation addressed the gap between promotional messaging and underlying evidence for skin, nail and hair claims, including the role of industry-linked research (PMID 34694676). Funding statements appear in each individual paper, and readers can verify them directly on the PubMed record rather than relying on summaries.
Can collagen peptides repair existing hair strands?▾
A 2025 materials study described a composite fish collagen peptide-based biopolymer emulsion developed for keratin structure stabilisation and hair fibre repair (PMID 40219297). That work addressed the hair shaft as a material, not follicular growth or shedding. A separate study used dissolving microneedles to deliver marine collagen peptide in an androgenetic alopecia context (PMID 37992979).
Track it. Calculate it. Actually understand it.
References
This page summarises published research for education. It is not medical advice, and nothing here is a recommendation to use, purchase, or dose any substance. Study parameters described are what researchers reported, not instructions. Consult a qualified clinician before any health decision.